WEIJING SUN, M.D.
Weijing Sun, MD is an Associate Professor of Medicine, University of Pennsylvania School of
Medicine; Attending physician of the University of Pennsylvania Health System; Director of
the Upper GI, Pancreatic, and Hepatobiliary Cancer Group, and Associate Director of GI
Cancer Program of the Abramson Cancer Center at the University of Pennsylvania. Board
certified in Internal Medicine and Medical Oncology; a member of the Global Health Programs
of the University.
Dr. Sun graduated from Shanghai Medical University (Fudan University). He had his Internal
Medicine residency training at the Loyola University Medical Center, and his
Hematology-Oncology fellowship training at the University of Pennsylvania.
Dr. Sun is focusing on the treatment and clinical research of GI malignances. He have
conducted many clinical trials for the development and evaluation of novel drugs and drug
combinations in GI cancer. These clinical trials that he oversees are funded through the NCI,
ECOG and pharmaceutical companies.
He has authored many publications including original clinical research articles, reviews, and
invited editorial commends in a variety of peer reviewed journals. He has also written chapters
as a GI oncology expert for several medical textbooks (e.g. WebMD, ACP Medicine, Textbook
of Gastroenterology). As an expert in GI oncology, Dr. Sun has been invited as a speaker and
faculty member for regional and national/international CME conferences.
Dr. Sun serves as a member of editorial board or review committee for several professional
journals (an editorial Board member of ‘Clinical Colorectal Cancer’, and a reviewer of
‘Journal of Clinical Gastroenterology’,’ Medical Science Monitor’, ‘The Cancer Biology and
Therapy’, ‘Disease of Colon and Rectum’, and ‘Expert Opinion on Investigational Drugs’).